Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Author index

Page Path
HOME > Browse articles > Author index
Search
Aye Aye Thi 1 Article
IBD
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review
Ebby George Simon, Richard Wardle, Aye Aye Thi, Jeanette Eldridge, Sunil Samuel, Gordon William Moran
Intest Res 2019;17(2):160-170.   Published online February 7, 2019
DOI: https://doi.org/10.5217/ir.2018.00114
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Fecal calprotectin (FC) is a highly sensitive disease activity biomarker in inflammatory bowel disease. However, there are conflicting reports on whether the diagnostic accuracy in Crohn’s disease is influenced by disease location. The aim of this study was to undertake a systematic review of the published literature. Relevant databases were searched from inception to November 8, 2016 for cohort and case control studies which had data on FC in patients with isolated small bowel (SB) and large bowel (LB) Crohn’s disease. Reference standards for disease activity were endoscopy, magnetic resonance imaging, computed tomography or a combination of these. The QUADAS-2 research tool was used to assess the risk of bias. There were 5,619 records identified at initial search. The 2,098 duplicates were removed and 3,521 records screened. Sixty-one full text articles were assessed for eligibility and 16 studies were included in the final review with sensitivities and specificities per disease location available from 8 studies. Sensitivities of FC at SB and LB locations ranged from 42.9% to 100% and 66.7% to 100% respectively while corresponding specificities were 50% to 100% and 28.6% to 100% respectively. The sensitivities and specificities of FC to accurately measure disease activity in Crohn’s disease at different disease locations are diverse and no firm conclusion can be made. Better studies need to be undertaken to categorically answer the effect of disease location on the diagnostic accuracy of FC.

Citations

Citations to this article as recorded by  
  • Unravelling metabolite-microbiome interactions in inflammatory bowel disease through AI and interaction-based modelling
    Rebecca Hodgkiss, Animesh Acharjee
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(3): 167618.     CrossRef
  • Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease
    Yuya Ogino, Kento Sadashima, Yuichiro Yoshida, Hironobu Takedomi, Nanae Tsuruoka, Yasuhisa Sakata, Ayako Takamori, Tadakazu Hisamatsu, Takayuki Matsumoto, Motohiro Esaki
    Journal of Gastroenterology.2025; 60(6): 705.     CrossRef
  • Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission
    Naohiro Nakamura, Yusuke Honzawa, Yuka Ito, Yasuki Sano, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Takashi Tomiyama, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui, Makoto Naganuma
    Intestinal Research.2025; 23(2): 170.     CrossRef
  • Serum food specific IgG antibodies are associated with small bowel inflammation in patients with Crohn’s disease
    Jintong Chen, Huaning Chen, Yanni Huang, Hongchai Xie, Silin Li, Chengdang Wang
    European Journal of Clinical Nutrition.2024; 78(1): 48.     CrossRef
  • Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn’s disease activity confirmed by balloon-assisted enteroscopy
    Ami Kawamoto, Kento Takenaka, Shuji Hibiya, Yoshio Kitazume, Hiromichi Shimizu, Toshimitsu Fujii, Eiko Saito, Kazuo Ohtsuka, Ryuichi Okamoto
    Intestinal Research.2024; 22(1): 65.     CrossRef
  • Which biomarkers best reflect the degree of inflammation in Crohn’s disease?
    Jihye Park
    Intestinal Research.2024; 22(1): 1.     CrossRef
  • RNA Expression of MMP12 Is Strongly Associated with Inflammatory Bowel Disease and Is Regulated by Metabolic Pathways in RAW 264.7 Macrophages
    Laura Arosa, Miguel Camba-Gómez, Luis Francisco Lorenzo-Martín, Laura Clavaín, Miguel López, Javier Conde-Aranda
    International Journal of Molecular Sciences.2024; 25(6): 3167.     CrossRef
  • Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis
    Amir Hossein Behnoush, Seyede Parmis Maroufi, Tara Reshadmanesh, Yasmin Mohtasham Kia, Mitra Norouzi, Seyedeh Mina Mohammadi, Aleksandra Klisic, Amirmohammad Khalaji
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
    Kyuwon Kim, Jae Jun Park, Hyuk Yoon, Jun Lee, Kyeong Ok Kim, Eun Sun Kim, Su Young Kim, Sun‐Jin Boo, Yunho Jung, Jun Hwan Yoo, Sung Wook Hwang, Sang Hyoung Park, Suk‐Kyun Yang, Byong Duk Ye
    Alimentary Pharmacology & Therapeutics.2024; 59(12): 1539.     CrossRef
  • Fecal Calprotectin in Patients with Crohn’s Disease: A Study Based on the History of Bowel Resection and Location of Disease
    Jeongkuk Seo, Subin Song, Seung Hwan Shin, Suhyun Park, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
    Diagnostics.2024; 14(8): 854.     CrossRef
  • Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn’s Disease: Real World Data from a Tertiary Center
    Nathaniel A. Cohen, Tenzin Choden, Emma C. Dyer, Nicole M. Garcia, Natalie K. Choi, David T. Rubin
    Digestive Diseases and Sciences.2024; 69(8): 2955.     CrossRef
  • Diagnostic Value of Quantitative Contrast‐Enhanced Ultrasound in Comparison to Endoscopy in Children With Crohn's Disease
    Slavojka Ponorac, Raja Dahmane Gošnak, Darja Urlep, Damjana Ključevšek
    Journal of Ultrasound in Medicine.2023; 42(1): 193.     CrossRef
  • Resistin, Elastase, and Lactoferrin as Potential Plasma Biomarkers of Pediatric Inflammatory Bowel Disease Based on Comprehensive Proteomic Screens
    Anto Sam Crosslee Louis Sam Titus, Kamala Vanarsa, Sanam Soomro, Anjali Patel, Jarod Prince, Subra Kugathasan, Chandra Mohan
    Molecular & Cellular Proteomics.2023; 22(2): 100487.     CrossRef
  • Fecal immunochemical test for haemoglobin versus fecal calprotectin to monitoring endoscopic activity in inflammatory bowel disease
    Patricia Latorre Añó, Jorge Torrente Sánchez, Amparo Almudena Pérez Ibañez, Jose María Tenias Burillo, Nadia Paloma Moreno Sánchez, Antonio López-Serrano, Eduardo Moreno Osset, Julián Murado Pardo, José María Paredes
    Revista Española de Enfermedades Digestivas.2023;[Epub]     CrossRef
  • Clinical Value of Detecting Fecal Calprotectin by Using Colloidal Gold Assay in Screening or Diagnosing Crohn’s Disease
    Wangdong Zhang, Yanyun Fan, Meijun Chen, Tatsuya Toyokawa
    Gastroenterology Research and Practice.2023; 2023: 1.     CrossRef
  • AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease
    Ashwin N. Ananthakrishnan, Jeremy Adler, Karen A. Chachu, Nghia H. Nguyen, Shazia M. Siddique, Jennifer M. Weiss, Shahnaz Sultan, Fernando S. Velayos, Benjamin L. Cohen, Siddharth Singh
    Gastroenterology.2023; 165(6): 1367.     CrossRef
  • Amplification of an Electrochemiluminescence-Emissive Aptamer into DNA Nanotags for Sensitive Fecal Calprotectin Determination
    Fujin Lv, Jialiang Chen, Ying Wan, Jingyi Si, Meiyan Song, Fulin Zhu, Songyuan Du, Yuzhe Shang, Tiantian Man, Longyi Zhu, Kewei Ren, Yuhao Piao, Changfeng Zhu, Sheng-Yuan Deng
    Analytical Chemistry.2023; 95(50): 18564.     CrossRef
  • Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
    Yoo Min Lee, Sujin Choi, Byung-Ho Choe, Hyo-Jeong Jang, Seung Kim, Hong Koh, Eun Sil Kim, Mi Jin Kim, Yon Ho Choe, Ben Kang
    Gut and Liver.2022; 16(1): 62.     CrossRef
  • Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
    Su Bum Park, Seong-Jung Kim, Jun Lee, Yoo Jin Lee, Dong Hoon Baek, Geom Seog Seo, Eun Soo Kim, Sang-Wook Kim, So Yeong Kim
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Fungi
    Jane Alookaran, Yuying Liu, Thomas A. Auchtung, Amirali Tahanan, Manouchehr Hessabi, Parisa Asgarisabet, Mohammad H. Rahbar, Nicole Y. Fatheree, Deborah A. Pearson, Rosleen Mansour, Melissa R. Van Arsdall, Fernando Navarro, J. Marc Rhoads
    Journal of Pediatric Gastroenterology and Nutrition.2022; 74(3): 377.     CrossRef
  • Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
    Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
    Intestinal Research.2022; 20(2): 203.     CrossRef
  • Ultrasonographic scores for ileal Crohn’s disease assessment: Better, worse or the same as contrast-enhanced ultrasound?
    M. Freitas, F. Dias de Castro, V. Macedo Silva, C. Arieira, T. Cúrdia Gonçalves, S. Leite, M. J. Moreira, J. Cotter
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease
    Michael Logan, Mary MacKinder, Clare Martha Clark, Aikaterini Kountouri, Mwansa Jere, Umer Zeeshan Ijaz, Richard Hansen, Paraic McGrogan, Richard K. Russell, Konstantinos Gerasimidis
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Usefulness of ultrasonography for small intestinal evaluations in pediatric Crohn's disease
    Takeru Okuhira, Atsushi Yoden, Emiri Kaji, Masano Otani‐Akamatsu, Keisuke Inoue, Tomoki Aomatsu, Kimitaka Takitani, Akira Ashida
    Pediatrics International.2022;[Epub]     CrossRef
  • Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
    José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset
    Intestinal Research.2022; 20(3): 361.     CrossRef
  • Fecal calprotectin predicts endoscopic activity and mucosal healing of small bowel Crohn’s disease evaluated by double-balloon endoscopy
    Wei Han, Juan Wu, Peipei Zhang, Naizhong Hu, Qiao Mei, Jing Hu
    International Journal of Colorectal Disease.2022; 37(9): 1953.     CrossRef
  • Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
    Cristina Romero-Mascarell, Gloria Fernández-Esparrach, Cristina Rodríguez-De Miguel, Maria Carme Masamunt, Sonia Rodríguez, Jordi Rimola, Miguel Urpí, Gherzon Simon Casanova, Ingrid Ordás, Elena Ricart, Berta Caballol, Agnès Fernández-Clotet, Julià Panés,
    Diagnostics.2022; 12(9): 2226.     CrossRef
  • A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities
    Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet
    Journal of Crohn's and Colitis.2021; 15(1): 152.     CrossRef
  • The utility of faecal and urine biomarkers for small bowel diseases
    M.S. Ismail, Serhiy Semenov, Deirdre McNamara
    Current Opinion in Gastroenterology.2021; 37(3): 284.     CrossRef
  • Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen
    Sanam Soomro, Suresh Venkateswaran, Kamala Vanarsa, Marwa Kharboutli, Malavika Nidhi, Ramya Susarla, Ting Zhang, Prashanth Sasidharan, Kyung Hyun Lee, Joel Rosh, James Markowitz, Claudia Pedroza, Lee A. Denson, Jeffrey Hyams, Subra Kugathasan, Chandra Moh
    Nature Communications.2021;[Epub]     CrossRef
  • Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk
    Sun-Ho Lee, Williams Turpin, Osvaldo Espin-Garcia, Juan Antonio Raygoza Garay, Michelle I. Smith, Haim Leibovitzh, Ashleigh Goethel, Dan Turner, David Mack, Colette Deslandres, Maria Cino, Guy Aumais, Remo Panaccione, Kevan Jacobson, Alain Bitton, A. Hill
    Gastroenterology.2021; 161(5): 1540.     CrossRef
  • Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn's Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review
    Eun Suk Jung, Sang Pyo Lee, Sea Hyub Kae, Jung Han Kim, Hyeong Su Kim, Hyun Joo Jang
    Gut and Liver.2021; 15(5): 732.     CrossRef
  • Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn's Disease
    Eun Soo Kim
    Gut and Liver.2021; 15(5): 637.     CrossRef
  • Diagnostic Accuracy of Non-Invasive Imaging for Detection of Colonic Inflammation in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Meshari T. Alshammari, Rebecca Stevenson, Buraq Abdul-Aema, Guangyong Zou, Vipul Jairath, Shellie Radford, Luca Marciani, Gordon W. Moran
    Diagnostics.2021; 11(10): 1926.     CrossRef
  • Közös felelősség a gyulladásos bélbetegség diagnosztikájában és kezelésében.
    Dóra Dohos, Adrienn Erős, Kata Szemes, Patrícia Sarlós
    Orvosi Hetilap.2021; 162(33): 1311.     CrossRef
  • Crohn's Disease Activity Quantified by Iodine Density Obtained From Dual-Energy Computed Tomography Enterography
    Bari Dane, Sean Duenas, Joseph Han, Thomas O'Donnell, Justin Ream, Shannon Chang, Alec Megibow
    Journal of Computer Assisted Tomography.2020; 44(2): 242.     CrossRef
  • Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases
    Gerard Honig, Caren Heller, Andrés Hurtado-Lorenzo
    Inflammatory Bowel Diseases.2020; 26(10): 1451.     CrossRef
  • Multiomic features associated with mucosal healing and inflammation in paediatric Crohn’s disease
    Henry Taylor, Jose Ivan Serrano‐Contreras, Julie A. K. McDonald, Jenny Epstein, JM Fell, Rocio C. Seoane, Jia V. Li, Julian R. Marchesi, Ailsa L. Hart
    Alimentary Pharmacology & Therapeutics.2020; 52(9): 1491.     CrossRef
  • Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease
    Shan-Shan Gong, Yi-Hong Fan, Qing-Qing Han, Bin Lv, Yi Xu
    World Journal of Gastroenterology.2019; 25(18): 2240.     CrossRef
  • Clinical value of fecal calprotectin
    Amanda Ricciuto, Anne M. Griffiths
    Critical Reviews in Clinical Laboratory Sciences.2019; 56(5): 307.     CrossRef
  • 14,122 View
  • 317 Download
  • 42 Web of Science
  • 40 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP